FDA issued a Warning Letter to Reine Lifescience on 5/9/2018 as a result of this inspection.
483 Reine Lifescience Nov 2017

483 Reine Lifescience Nov 2017

Dipesh Shah FDA$119.00 - Available Now

FDA investigators audited the Reine Lifescience - Ankleshwar, India facility and issued inspectional observations (via FDA 483) on 03 Nov 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 03 Nov 2017
  • Location: Ankleshwar, India
  • FEI: 3011543431
Add To Cart